Research on the therapeutic effect of peripheral blood mononuclear cells infusion from donors stimulated with granulocyte colony-stimulating factor in the treatment of patient with relapsed leukemia after allogeneic hematopoietic stem cell transplantation

Liu Jia,Gao Li,Chen Xinghua,Liu Yao,Gao Lei,Zhang Cheng,Zhang Xi

DOI: https://doi.org/10.3969/j.issn.1673-4130.2011.11.003

2011-01-01

Abstract:Objective To investigate the efficacy and safety of growth factor-primed donor hematopoietic stem cells infusion(GPBSCI)from donors stimulated with granulocyte colony-stimulating factor(G-CSF) in the treatment of patients with relapsed leukemia after allogeneic hematopoietic stem cell transplantation(allo-HSCT).Methods 20 cases of patients with relapsed leukemia,occurring in six months after allo-HSCT,among whom 5 cases were acute lymphoblastic leukemia(ALL) in CR2,8 were acute myeloid leukemia(AML) in CR2,2 were AML in CR3,3 were acute mixed lineage leukemia(MAL) and 2 were chronic myeloid leukemia at accelerated phase,received GPBSCI,during Jul.2009 to Feb.2011.The dose of cells infusion was 1×105/kg for the first time,2×105/kg for the second time,4×105/kg for the third time and so on,and the cells infusion was performed once for every four weeks.Results After receiving GPBSCI,12 patients received complete remission again,3 patients developed grade Ⅰ-Ⅱ acute GVHD,12 patients developed chronic GVHD,5 patients had not any complication and no transfusion related pancytopenia was observed in all patients.Conclusion This research could suggest that GPBSCI might be an effective method for the treatment of patients with relapsed leukemia after allo-HSCT,which deserves further study and extended clinical application.